Rossi: Skype Testing is With Multiple Companies Around the World.

After my previous post regarding Andrea Rossi doing Skype testing, some readers had pointed out that Andrea Rossi mentioned “clients”, rather than a single client. I thought that was an important point, so yesterday I decided to follow up on the Journal of Nuclear Physics with another question on the subject.

Frank Acland
April 27, 2020 at 7:21 AM
Dear Andrea,

Are you currently doing the online/skype testing you describe with just one company, or are you doing it with multiple companies?

His reply:

Andrea Rossi
April 27, 2020 at 1:39 PM
Frank Acland:
I am doing the test via Skype with companies of America, Europe, Asia and Africa.
Warm Regards,

This response was quite surprising to me because I had assumed that the testing was with one party only. That there are apparently multiple companies involved makes the situation quite interesting, and probably quite efficient for Rossi if he is trying to generate interest in his E-Cat. By doing it all online, he probably feels his IP is quite secure (he says the E-Cats are with him), and he can do the same kinds of experiments with different companies from his lab which saves him the time and expense that would be involved in travel.

There will have to come a point, however, where customers will want and need to have hands-on experience with the E-Cat. No company is going to make a business decision on a product like this unless they have absolute knowledge that it is working as claimed, even if Skype tests seem convincing.

Rossi says ‘Client’ is a Potential Global Partner

I keep trying to get a clearer understanding of the current situation with the E-Cat, in terms of the business plan. It occurred to me that the reason the testing situation is so important, (which has been hampered due to the coronavirus pandemic) could be because the results will determine whether a deal with a global company is reached. So I asked Andrea Rossi about this on the Journal of Nuclear Physics:

Frank Acland

Dear Andrea,

I want to see if I am understanding correctly:

You said the party you are currently doing testing with (remotely for now) is a client:
1- who is paying for the the testing ?
2- Is this client also a potential global partner (dependant on the results of the testing)?

Many thanks and best wishes,

Frank Acland


Rossi’s response:

Andrea Rossi
April 26, 2020 at 3:12 AM
Frank Acland:
1- the clients
2- yes
Warm Regards,

From earlier comments by Rossi, he has said that so far, no one has made an E-Cat SKL independently from himself. To me, this suggests that Rossi is withholding certain information about the E-Cat until he has reached a deal that he finds satisfactory. And from the perspective of a client, they want to be completely sure that the E-Cat technology is the real deal before they do a deal with Rossi.

It appears that the coronavirus situation requires that for now the only testing that can take place is remotely. Rossi has said that ideally, the testers will come to him and/or he will go to them, but this is not currently possible.

Posted in Uncategorized | Tagged

COVID-19 Thread 4/24/2020 (Australian Company Claims “Remarkable” Success with Stem Cell Treatment)

A Melbourne-based medicine company called Mesoblast has published a press release in which it claims that COVID-19 patients on ventilator support have responded very well to being treated with their product remestemcel-L, which they describe as an “allogeneic cell therapy”. The treatment is usually used to treat disease in people who have had bone marrow transplants, and is being used to treat COVID-19 patients on a compassionate use basis.

From the press release:

Key points:

• 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated with two infusions of Mesoblast’s allogeneic cell therapy remestemcel-L within the first five days under emergency compassionate use at New York City’s Mt Sinai hospital during the period March-April 2020

• 75% (9/12) have successfully come off ventilator support within a median of 10 days

• These results contrast with only 9% of ventilator-dependent COVID-19 patients being able to come off
ventilators with standard of care treatment and only 12% survival in ventilator-dependent COVID-19 patients at two major referral hospital networks in New York during the same time period

• This compassionate use treatment experience has informed the design of the clinical protocol for the
randomized, placebo-controlled Phase 2/3 trial of remestemcel-L in ventilator-dependent COVID-19
moderate/severe ARDS patients across North America

COVID-19 Thread 4/23/2020 (Researchers Suggest Temperature and Humidity Affect Virus Spread)

Researchers at the Institute of Virology at the University of Maryland suggest that there is a relationship between climate and how efficiently coronavirus spreads in communities.

‘In a new paper published on the open-data site SSRN, the researchers found that all cities experiencing significant outbreaks of COVID-19 have very similar winter climates with an average temperature of 41 to 52 degrees Fahrenheit, an average humidity level of 47 to 79 percent with a narrow east-west distribution along the same 30-50 N” latitude. This includes Wuhan, China, South Korea, Japan, Iran, Northern Italy, Seattle, and Northern California. It could also spell increasing trouble for the Mid-Atlantic States and — as temperatures rise — New England.

‘“Based on what we have documented so far, it appears that the virus has a harder time spreading between people in warmer, tropical climates,” said study leader Mohammad Sajadi, MD, Associate Professor of Medicine in the UMSOM, physician-scientist at the Institute of Human Virology and a member of GVN.’

The paper referenced is titled “Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19” and is available at:

COVID-19 Thread 4/21/2020 (Researchers Report More Encouraging Results using Remdesivir Treatment))

U.S. News is reporting that researchers reporting early results from clinical trials using Gilead Sciences’ drug remdesivir to treat COVID-19 patients with both moderate and severe disease is encouraging.

‘A number of the patients are now recovering and have been released from the hospital. While it’s too early to tell, the researchers said there are also indications that remdesivir can possibly stave off being put on a ventilator.

‘”Early results are promising, and that is important right now. Much of what we are learning about COVID-19 management is centered around preventing quick deterioration. Timing is everything. I can’t say for certain they [patients] would have been intubated otherwise, but it’s encouraging,” said Katherine Perez, an infectious diseases pharmacist who is co-leading the trials.

[. . .]

‘Quick treatment is critical, said Dr. Kevin Grimes, an infectious diseases physician and co-leader of the trials.

‘”If given early enough, we’re hoping that remdesivir interferes with the virus and blocks its ability to replicate in patients’ cells,” Grimes said in a Houston Methodist news release. “The goal is that it staves off the deadly inflammatory cascade that leads to respiratory failure and the need to be intubated and put on a ventilator.”

U.S. Crude Oil Contract Price Turns Negative

We have all probably been noticing that the coronavirus pandemic has hit the oil market extremely hard with prices dropping sharply over recent months. A very strange thing happened yesterday with the price U.S. WTI Crude Oil May contract settling in negative territory for the first time, settling at – [minus] $37.

Here’s a little commentary on the situation from CNBC’s ‘Mad Money’ show with Jim Cramer in which his guest Rusty Braziel CEO of RBN Energy, who explains that the current situation does not apply to the physical market, but calls it a ‘paper market’ problem. He does say it is possible that the physical price of oil could go negative at some point if demand continues to dry up due to coronavirus impacts, and storage facilities are filled.

Posted in Uncategorized | Tagged

SOWHAT! – Self Organization Will Hasten Advanced Technology Transition (‘Director’)

The following post has been submitted by ECW reader ‘Director’

SOWHAT! – Self Organization Will Hasten Advanced Technology Transition

By: The Director

Humans have major issues. Monetary greed, unchecked ambition, dogmatic belief systems: these are only a few of the reasons why humanity is utilizing technologies from the 1920’s in the 2020’s. The deep corruption that runs through government agencies, corporate entities, and academic circles have hindered humanity’s progress towards a more complete mastery of physical reality. Although a significant number of inventors over the last century attempted to pierce the barriers that impede radical new technologies, they all failed. Only now, in the past few years, has the self organizing plasma phenomena that united them been fully recognized. This fundamental natural process seen in a multitude of environments and at all scales – atomic to galactic – is finally out. Like the coronavirus, its high transmissability has insured that all efforts to “put it back into the bottle” will be futile. So what if this leads to the end of the fossil fuel age; so what if this leads to a deeper understanding of physical reality, so what if this exposes ultra advanced propulsion technologies. The future of our species is vastly more important than protecting the financial portfolios of billionaires.

Entropy makes systems fall into states of disorganization. Without intense effort, a house will become messy with dirty carpets, piles of laundry, stacks of dishes, and dust covered surfaces. This is also true of the human body: although we are programmed to repair ourselves we start to malfunction as we enter middle age and totally fall apart in our senior years. This concept is also demonstrated in physics: how heat will disperse through a substance until an equilibrium with the environment is reached. Yet in certain circumstances, plasmas – volumes of ionized heavy particles and electrons – can operate in reverse to become more organized. The application of radio or microwave frequencies, sudden electrical discharges, differences in electrical potential, and other mechanisms can induce the spontaneous creation of complex structures. Some of the most relevant to those following the emergence of exotic energy technologies are what have been described as “fire balls”, “complex space charge configurations”, “exotic vacuum objects”, and even “plasma balls.”

These structures have similarities to living organisms. For example, a “fireball” has an exterior membrane with a layer of electrons on one side and positive ions on the other: what’s called an electrical double layer. This allows the structure to have a defined volume and store energy like a capacitor. Even more interestingly, they continuously absorb and emit matter and energy through these double layers – like a cell consuming nutrients and then excreting waste. Other characteristics observed are their ability to grow in size, adapt to conditions, combine, divide, and even storing information. Although they are ubiquitous in nature and exist even in our own bodies, what’s most relevant for our discussion is that they can produce a wide range of anomalies that seem to defy mainstream scientific thought: the religions dogma that academic institutions indoctrinate their students with year after year. The one this article will focus on is excess energy production in multiple forms. Electromagnetic radiation, light, heat, and direct electrical output can all be produced from these self organizing plasmas. Perhaps the exact mechanisms that allow for this generation of energy are not fully understood – but it’s generated anyway.

The setups that produce self organizing plasmas have been around for over a hundred years. They are aren’t new. One such configuration that will produce a “free floating fireball” is the low voltage DC discharge. Imagine one cathode (negatively charged) and one anode (positively charged) on either side of a sealed discharge tube. If the parameters in the reactor are suitable – such as having a low enough atmospheric pressure to be able to ignite the discharge without an extremely high voltage – the creation of such a self organizing plasma is simple. All you must do is crank up the input power until you reach what’s called the “negative differential resistance” regime in which the current and voltage relationship is flip flopped. During this regime the electrical resistance of the plasma will drop dramatically due to the formation of the double layers of the self organizing plasma. If you can restrict the current so that a true arc discharge is not established, a “fire ball” will form that will float somewhere between the two electrodes. There’s nothing complicated about this process. It will happen each and every time.

This plasma ball that formed out of the electrons and positive ions of the plasma is indeed special. It has a higher density and electron energy than the general plasma. And, if you utilize an optimal gas combination (hydrogen or deuterium plus a heavier gas like nitrogen, argon, mercury, etc) while adjusting the conditions of the reactor to maximize the self organization, excess energy will be produced. Although The SAFIRE Project, Andrea Rossi, and Brilliant Light Power are all utilizing different systems, this self organizing process is at the heart of all their technologies. The “big three” all have far more in common than most people realize.

The result of the fact that these systems are all utilizing the self organizing plasma phenomena makes them all easily reproducible. I would go so far as to say that if a team were to assemble to investigate this general phenomena with a well equipped laboratory, they’d find them remarkably easy to generate on demand. Even more importantly, due to the simplicity of working with pure plasma systems, a researcher could perform a dozen different tests in the same time it would take to process and test a single batch of traditional LENR fuel (such as specially sized, degassed, hydrogenated, and spillover catalyst coated nickel powder). Moreover, the variability between experiments would be reduced as well: making hydrogen or deuterium absorb into bulk or even powdered materials is a ridiculously tricky process. In a pure plasma based system, you’re avoiding all that and simply producing a macro-scale self organizing plasma that can be generated in the exact same manner again and again.

The importance of the self organizing plasma phenomena cannot be understated. We now have a direct path towards building devices that can rival even the most optimistic dreams of cold fusion researchers in regards to classical electrolytic or gas loading systems. But what are we going to do with this knowledge? Obviously, some parties are moving forward, including The SAFIRE Project, Andrea Rossi, and Brilliant Light Power. But we need more players to emerge. Eventually, if the global economy doesn’t completely collapse, I expect more will arrive eventually. The sooner they can start performing experiments and openly posting their results the better. What’s important now is to accelerate the global acceptance of the potential of self organizing plasmas. This phenomena can allow for energy producing devices that dwarf the significance of even the most efficient, low cost solar panels. So the world must be awakened to the fact they are every bit as real as photovoltaic devices. Once this happens, the race will be on and humanity will be on a path that will transition our civilization to the next level in which we become something better. Let’s make this happen sooner rather than later.

Posted in Uncategorized | Tagged

Rossi ‘Taking Advantage’ of Coronavirus Period to Improve E-Cat SKL

I asked Andrea Rossi yesterday on the Journal of Nuclear Physics what tasks he was doing these days in terms of the development of the E-Cat SKL.
His response:
Andrea Rossi

Frank Acland:
Measurements aimed to obtain the highest possible efficiency combined with the maximum possible reliability. Designing and redesigning the assebly.
Until we are in the period of grace of the R&D the modifications are fast and cheap, while when we will be in the phase of massive production , modifications will be very expensive. So we must now make all the possible tests and combinations, and compare the results. The corona virus period can be taken advantage of as a sort of an incubator of improvements: any negative event must be turned into a positive chance, which is what I always made in the not easy course of my life.
Warm Regards,

Also, Gerard McEk asked Rossi about his working situation:

Gerard McEk

Dear Andrea,
1. I would guess that the tests have already been finalized and that you are now waiting for the reports, is that right?
2. You obviously took all your stuff to Europe somewhere, where you are continuing your development. I assume it was brought by plane. Does it really take so little equipment to design, built and test the E-Cat SKL?

Rossi’s response:

Andrea Rossi
April 18, 2020 at 7:59 AM
Gerard McEk:
1- no
2- We have most of the equipment necessary to make the Ecats in the USA. Here I have only the instrumentation necessary to work on a prototype and make all the necessary measurements, but the production is there and from there I continue to receive what I need incliding new features.

So from this it sounds like Rossi is saying that the production of E-Cat parts is taking place in the US, while he himself is in Europe working on prototypes, getting materials sent to him from the U.S. as needed.

Posted in Uncategorized | Tagged

COVID-19 Thread 4/18/2020 (French Doctors Treating with Azithromycin and Zinc)

Here’s an article about three French doctors treating COVID-19 patients with a combination of azithromycin and zinc.

3 French Doctors Are Using Azithromycin With Zinc to Treat Coronavirus

“Inspired by Previous work on the combination of hydrochloroquine and azithromycin, three doctors practicing in the Moselle in northern France have tested a new treatment on hundreds of patients. Not able to prescribe chloroquine which can only be prescribed in hospital, they prescribed to their coronavirus patients the antibiotic azithromycin along with zinc to increase its effectiveness, while patients with asthma were also prescribed Singulair (montelukast), which has anti-inflammatory properties.

“Dr. Gastaldi added that he prescribed this combination to over 200 patients. Statistically, among them he would have had at least 2 deaths and 40 hospitalizations. However, he explains that he had only two serious cases that required hospitalization and have since been discharged.

“These encouraging results are reinforced by the diversity of his clientele of all ages and some with risk factors. One of Dr. Gastaldi colleagues, Dr. Erbstein, also stressed that none of his patients required hospitalization and so far none have died.”

This article in French provides the source material used for the Gilmore Health article:

COVID-19 Thread 4/16/2020 (Clincal Trial Shows Drug Remdesivir Effective Treatment)

An article on the Statnews website reports about some apparent success treating COVID-19 patients with the Gilead drug remdesivir in a clinical trial at a Chicago hospital.

From the article:

‘The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.

‘“The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.’

The full article can be read here:

This report has apparently contributed to steep gains in stock market futures in the U.S. financials markets ahead of Friday’s market opening.